InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-37.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Explore the full record of transactions filed by Barrett Scott, Directeur Médical. Officer active across 1 company, notably Immuneering Corp. Cumulatively, 2 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 22 March 2022. The latest transaction was filed on 22 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Barrett Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
900 股@ US$7.485100.0% 占其流量Class A Common StockSEC:0001415889-22-003270:0
标准退出：2022年6月20日 (T+90)
5,996 股Class A Common StockSEC:0001104659-21-099725:0
2 条申报中的 2 条
About Barrett Scott
Scott Barrett is the Chief Medical Officer at Immuneering Corp. He oversees the company's medical and clinical initiatives, ensuring innovation and scientific advancement. His expertise is essential for Immuneering's success in the biopharmaceutical field.
